OVERCOMING PARP INHIBITOR RESISTANCE BY TARGETING THE ATR-CHK1 PATHWAY IN BRCA 1/2-DEFICIENT OVARIAN CANCER

$479,999FY2016Department of the ArmyDOD

Trustees Of The University Of Pennsylvania, The

Investigators

OVERCOMING PARP INHIBITOR RESISTANCE BY TARGETING THE ATR-CHK1 PATHWAY IN BRCA 1/2-DEFICIENT OVARIAN CANCER · GrantIndex